Comprehensive Genomic Data Deposition for Pancreatic Cancer Precision Medicine Studies: Clinical Trials NCT02451982 and NCT02648282

ANALYTE_TYPE - Analyte type (phv00537539.v1.p1)
BODY_SITE - Body site where sample was collected (phv00537538.v1.p1)
CONSENT - Consent group as determined by DAC (phv00537533.v1.p1)
HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00537541.v1.p1)
IS_TUMOR - Tumor status (phv00537540.v1.p1)
SAMPLE_ID - Sample ID. NOTE: "pre" and "post" in sample IDs indicate the timing of sample collection relative to treatment. However, not all subjects provided a pre-treatment sample, particularly when their treatment did not occur. In these cases "post" refers to post-operative treament/sample collection. (phv00537537.v1.p1)
SAMPLE_ID - Sample ID (phv00537536.v1.p1)
SUBJECT_ID - Subject ID (phv00537532.v1.p1)
SUBJECT_ID - Subject ID (phv00537535.v1.p1)
TUMOR_GRADE - Tumor grade of sample (phv00537543.v1.p1)
TUMOR_STAGE - Tumor stage of sample (phv00537542.v1.p1)